OBJECTIVE: Deficits in reward processing are established in mood and substance use disorders and are known risk factors for these disorders. Volume reductions of the orbitofrontal cortex and the striatum, regions that subserve neural response to reward, have been shown to be related to anhedonia in depressive and substance use disorders. The authors sought to investigate how structural maturation of these regions in childhood varies with level of anhedonia and predicts later substance use. METHOD: The study employed data from a sample of depressed and healthy preschoolers studied longitudinally that included three waves of neuroimaging from school age to adolescence. Three years after scan 3, at ages 13-18, participants underwent a comprehensive behavioral and substance use assessment. Multilevel modeling was used to investigate the relationship between anhedonia and the growth trajectories of the striatum and orbitofrontal cortex. Zero-inflated Poisson regression models were then used to determine whether the intercepts and slopes of these trajectories predicted later alcohol and marijuana use frequency in adolescence. RESULTS: The anhedonia-by-age interaction was significant in the multilevel modeling of orbitofrontal cortical but not striatal volume. Higher anhedonia ratings were significantly associated with steeper decline in orbitofrontal cortical volume with age. Orbitofrontal cortical volume and thickness at age 12 and trajectory over time significantly and negatively predicted subsequent alcohol and marijuana use frequency but not depression during adolescence. CONCLUSIONS: The findings suggest that the development of the orbitofrontal cortex during childhood is strongly linked to experiences of anhedonia and that these growth trajectories predict substance use during a developmentally critical period.
OBJECTIVE: Deficits in reward processing are established in mood and substance use disorders and are known risk factors for these disorders. Volume reductions of the orbitofrontal cortex and the striatum, regions that subserve neural response to reward, have been shown to be related to anhedonia in depressive and substance use disorders. The authors sought to investigate how structural maturation of these regions in childhood varies with level of anhedonia and predicts later substance use. METHOD: The study employed data from a sample of depressed and healthy preschoolers studied longitudinally that included three waves of neuroimaging from school age to adolescence. Three years after scan 3, at ages 13-18, participants underwent a comprehensive behavioral and substance use assessment. Multilevel modeling was used to investigate the relationship between anhedonia and the growth trajectories of the striatum and orbitofrontal cortex. Zero-inflated Poisson regression models were then used to determine whether the intercepts and slopes of these trajectories predicted later alcohol and marijuana use frequency in adolescence. RESULTS: The anhedonia-by-age interaction was significant in the multilevel modeling of orbitofrontal cortical but not striatal volume. Higher anhedonia ratings were significantly associated with steeper decline in orbitofrontal cortical volume with age. Orbitofrontal cortical volume and thickness at age 12 and trajectory over time significantly and negatively predicted subsequent alcohol and marijuana use frequency but not depression during adolescence. CONCLUSIONS: The findings suggest that the development of the orbitofrontal cortex during childhood is strongly linked to experiences of anhedonia and that these growth trajectories predict substance use during a developmentally critical period.
Entities:
Keywords:
Anhedonia; Orbitofrontal Cortex Development; Substance Use
Authors: J N Giedd; J Blumenthal; N O Jeffries; F X Castellanos; H Liu; A Zijdenbos; T Paus; A C Evans; J L Rapoport Journal: Nat Neurosci Date: 1999-10 Impact factor: 24.884
Authors: Chi-Hua Chen; Mark Fiecas; E D Gutiérrez; Matthew S Panizzon; Lisa T Eyler; Eero Vuoksimaa; Wesley K Thompson; Christine Fennema-Notestine; Donald J Hagler; Terry L Jernigan; Michael C Neale; Carol E Franz; Michael J Lyons; Bruce Fischl; Ming T Tsuang; Anders M Dale; William S Kremen Journal: Proc Natl Acad Sci U S A Date: 2013-09-30 Impact factor: 11.205
Authors: Francesca M Filbey; Sina Aslan; Vince D Calhoun; Jeffrey S Spence; Eswar Damaraju; Arvind Caprihan; Judith Segall Journal: Proc Natl Acad Sci U S A Date: 2014-11-10 Impact factor: 11.205
Authors: Lindsay M Squeglia; Susan F Tapert; Edith V Sullivan; Joanna Jacobus; M J Meloy; Torsten Rohlfing; Adolf Pfefferbaum Journal: Am J Psychiatry Date: 2015-05-18 Impact factor: 18.112
Authors: Joanna Jacobus; Lindsay M Squeglia; Alejandro D Meruelo; Norma Castro; Ty Brumback; Jay N Giedd; Susan F Tapert Journal: Dev Cogn Neurosci Date: 2015-04-27 Impact factor: 6.464
Authors: Wan-Ling Tseng; Christen M Deveney; Joel Stoddard; Katharina Kircanski; Anna E Frackman; Jennifer Y Yi; Derek Hsu; Elizabeth Moroney; Laura Machlin; Laura Donahue; Alexandra Roule; Gretchen Perhamus; Richard C Reynolds; Roxann Roberson-Nay; John M Hettema; Kenneth E Towbin; Argyris Stringaris; Daniel S Pine; Melissa A Brotman; Ellen Leibenluft Journal: Am J Psychiatry Date: 2018-10-19 Impact factor: 18.112
Authors: Danielle S Kroll; Dana E Feldman; Szu-Yung Ariel Wang; Rui Zhang; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang Journal: J Neurol Sci Date: 2020-08-19 Impact factor: 3.181
Authors: Elizabeth Kwon; Tom Hummer; Katharine D Andrews; Peter Finn; Matthew Aalsma; Allen Bailey; Jocelyne Hanquier; Ting Wang; Leslie Hulvershorn Journal: Drug Alcohol Depend Date: 2020-12-31 Impact factor: 4.492
Authors: Haixia Zheng; Maurizio Bergamino; Bart N Ford; Rayus Kuplicki; Fang-Cheng Yeh; Jerzy Bodurka; Kaiping Burrows; Peter W Hunt; T Kent Teague; Michael R Irwin; Robert H Yolken; Martin P Paulus; Jonathan Savitz Journal: Neuropsychopharmacology Date: 2021-01-26 Impact factor: 7.853
Authors: Lia Ferschmann; Nandita Vijayakumar; Håkon Grydeland; Knut Overbye; Donatas Sederevicius; Paulina Due-Tønnessen; Anders M Fjell; Kristine B Walhovd; Jennifer H Pfeifer; Christian K Tamnes Journal: Dev Cogn Neurosci Date: 2019-11-06 Impact factor: 6.464
Authors: Yara J Toenders; Laura S van Velzen; Ivonne Z Heideman; Ben J Harrison; Christopher G Davey; Lianne Schmaal Journal: Dev Cogn Neurosci Date: 2019-08-08 Impact factor: 6.464